Rainier Acquisition Corporation Class A Ordinary Shares

Rainier Acquisition Corporation Class A Ordinary Shares(RNAQ)股票分析

$9.980

0.000 (0.00%)收盤時

Loading chart…
最高
9.980
開盤
9.980
成交量加權均價
9.98
成交量
20.00
市值
—
最低
9.980
成交金額
199.60
企業價值/稅息折舊攤銷前利潤(TTM)
0.00

Rainier Acquisition Corporation is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. The Company has not selected any business combination, has conducted no operations and has generated no revenues. It intends to focus on life sciences companies that apply biology to improve human health.

AI 分析 of Rainier Acquisition Corporation Class A Ordinary Shares (RNAQ)

賣出

Rainier Acquisition Corp (RNAQ) is not a good buy right now due to its low current ratio of 0.18, indicating potential liquidity issues, and a negative total equity of -7293.00 USD, which raises concerns about its financial health. Additionally, the stock is trading at a 52-week low of 9.90, which is only 13.3% of its 52-week range, suggesting it is underperforming. The RSI is at 38.423, indicating it is nearing oversold conditions but lacks a strong buy signal. The main risk is its total debt of 25000.00 USD against its low current assets of 17707.00 USD, which could lead to financial instability.

估值指標

Rainier Acquisition Corporation Class A Ordinary Shares(RNAQ)目前預期本益比為 0.00,5 年平均預期本益比為 。

預期本益比

5 年均值 P/E
目前P/E
0.00

預期 EV/EBITDA

5 年均值 EV/EBITDA
目前EV/EBITDA
0.00

預期股價營收比

5 年均值 P/S
目前P/S
0.00

事件時間軸

2026-09-21 (ET)

16:00:00

Nscale Limited Files for IPO, Plans to List on NYSE

RNAQ 常見問題 —— 由 Alphio AI 解答

Rainier Acquisition Corporation is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. The Company has not selected any business combination, has conducted no operations and has generated no revenues. It intends to focus on life sciences companies that apply biology to improve human health.

Rainier Acquisition Corp (RNAQ) is not a good buy right now due to its low current ratio of 0.18, indicating potential liquidity issues, and a negative total equity of -7293.00 USD, which raises concerns about its financial health. Additionally, the stock is trading at a 52-week low of 9.90, which is only 13.3% of its 52-week range, suggesting it is underperforming. The RSI is at 38.423, indicating it is nearing oversold conditions but lacks a strong buy signal. The main risk is its total debt of 25000.00 USD against its low current assets of 17707.00 USD, which could lead to financial instability.

暫無貼文

註冊或登入後參與討論

相關文章

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易